| Revenue Disaggregation |
| Note 10. |
Revenue Disaggregation |
The Company generates product revenues from products
which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services
which are provided to medical device manufacturers.
The following table presents the Company’s disaggregated
revenues by revenue source:
| Schedule of disaggregated revenue by source |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| Human Care |
|
$ |
2,957,000 |
|
|
$ |
2,075,000 |
|
|
$ |
5,833,000 |
|
|
$ |
4,825,000 |
|
| Animal Care |
|
|
402,000 |
|
|
|
489,000 |
|
|
|
801,000 |
|
|
|
1,067,000 |
|
| Service and Royalty |
|
|
220,000 |
|
|
|
167,000 |
|
|
|
336,000 |
|
|
|
266,000 |
|
| |
|
$ |
3,579,000 |
|
|
$ |
2,731,000 |
|
|
$ |
6,970,000 |
|
|
$ |
6,158,000 |
|
The following table shows the Company’s revenues
by geographic region:
| Schedule of revenues by geographic region |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| United States |
|
$ |
675,000 |
|
|
$ |
590,000 |
|
|
$ |
1,317,000 |
|
|
$ |
1,396,000 |
|
| Europe |
|
|
1,506,000 |
|
|
|
1,201,000 |
|
|
|
2,794,000 |
|
|
|
2,271,000 |
|
| Asia |
|
|
776,000 |
|
|
|
346,000 |
|
|
|
1,253,000 |
|
|
|
1,208,000 |
|
| Latin America |
|
|
465,000 |
|
|
|
260,000 |
|
|
|
1,345,000 |
|
|
|
747,000 |
|
| Rest of the World |
|
|
157,000 |
|
|
|
334,000 |
|
|
|
261,000 |
|
|
|
536,000 |
|
| Total |
|
$ |
3,579,000 |
|
|
$ |
2,731,000 |
|
|
$ |
6,970,000 |
|
|
$ |
6,158,000 |
|
|